- As used in this chapter:
-
(a) “Autoimmune disease” means any disease that results from an aberrant immune response, including, without limitation:
-
(1) Acute Disseminated Encephalomyelitis (ADEM)
-
(2) Acute necrotizing hemorrhagic leukoencephalitis
-
(3) Addison’s disease
-
(4) Agammaglobulinemia
-
(5) Alopecia areata
-
(6) Amyloidosis
-
(7) Ankylosing spondylitis
-
(8) Anti-GBM/Anti-TBM nephritis
-
(9) Antiphospholipid syndrome (APS)
-
(10) Autoimmune angioedema
-
(11) Autoimmune aplastic anemia
-
(12) Autoimmune dysautonomia
-
(13) Autoimmune hepatitis
-
(14) Autoimmune hyperlipidemia
-
(15) Autoimmune immunodeficiency
-
(16) Autoimmune inner ear disease (AIED)
-
(17) Autoimmune myocarditis
-
(18) Autoimmune oophoritis
-
(19) Autoimmune pancreatitis
-
(20) Autoimmune retinopathy
-
(21) Autoimmune thrombocytopenic purpura (ATP)
-
(22) Autoimmune thyroid disease
-
(23) Autoimmune urticaria
-
(24) Axonal & neuronal neuropathies
-
(25) Balo disease
-
(26) Beheet’s disease
-
(27) Bullous pemphigoid
-
(28) Cardiomyopathy
-
(29) Castleman disease
-
(30) Celiac disease
-
(31) Chagas disease
-
(32) Chronic fatigue syndrome
-
(33) Chronic inflammatory demyelinating polyneuropathy (CIDP)
-
(34) Chronic recurrent multifocal ostomyelitis (CRMO)
-
(35) Churg-Strauss syndrome
-
(36) Cicatricial pemphigoid/benign mucosal pemphigoid
-
(37) Crohn’s disease
-
(38) Cogans syndrome
-
(39) Cold agglutinin disease
-
(40) Congenital heart block
-
(41) Coxsackie myocarditis
-
(42) CREST disease
-
(43) Essential mixed cryoglobulinemia
-
(44) Demyelinating neuropathies
-
(45) Dermatitis herpetiformis
-
(46) Dermatomyositis
-
(47) Devic’s disease (neuromyelitis optics)
-
(48) Discoid lupus
-
(49) Dressler’s syndrome
-
(50) Endometriosis
-
(51) Eosinophilic esophagitis
-
(52) Eosinophilic fasciitis
-
(53) Erythemanodosum
-
(54) Experimental allergic encephalomyelitis
-
(55) Evans syndrome
-
(56) Fibromyalgia
-
(57) Fibrosing alveolitis
-
(58) Giant cell arteritis (temporal arteritis)
-
(59) Giant cell myocarditis
-
(60) Glomerulonephritis
-
(61) Goodpasture’s syndrome
-
(62) Granulomatosis with Polyangiitis (GPA) (formerly called Wegener’s Granulomatosis)
-
(63) Graves’ disease
-
(64) Guillain-Barre syndrome
-
(65) Hashimoto’s encephalitis
-
(66) Hashimoto’s thyroiditis
-
(67) Hemolytic anemia
-
(68) Henoch-Schonlein purpura
-
(69) Herpes gestationis
-
(70) Hypogammaglobulinemia
-
(71) Idiopathic thrombocytopenic purpura (ITP)
-
(72) IgA nephropathy
-
(73) IgG4-related sclerosing disease
-
(74) Immunoregulatory lipoproteins
-
(75) Inclusion body myositis
-
(76) Interstitial cystitis
-
(77) Juvenile arthritis
-
(78) Juvenile diabetes (Type 1 diabetes)
-
(79) Juvenile myositis
-
(80) Kawasaki syndrome
-
(81) Lambert-Eaton syndrome
-
(82) Leukocytoclastic vasculitis
-
(83) Lichen planus
-
(84) Lichen sclerosus
-
(85) Ligneous conjunctivitis
-
(86) Linear IgA disease (LAD)
-
(87) Lupus (SLE)
-
(88) Lyme disease, chronic
-
(89) Meniere’s disease
-
(90) Microscopic polyangiitis
-
(91) Mixed connective tissue disease (MCTD)
-
(92) Mooren’s ulcer
-
(93) Mucha-Habermann disease
-
(94) Multiple sclerosis
-
(95) Myasthenia gravis
-
(96) Myositis
-
(97) Narcolepsy
-
(98) Neuromyelitis optica (Devic’s)
-
(99) Neutropenia
-
(100) Ocular cicatricial pemphigoid
-
(101) Optic neuritis
-
(102) Palindromic rheumatism
-
(103) PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus)
-
(104) Paraneoplastic cerebellar degeneration
-
(105) Paroxysmal nocturnal hemoglobinuria (PNH)
-
(106) Parry Romberg syndrome
-
(107) Parsonnage-Turner syndrome
-
(108) Pars planitis (peripheral uveitis)
-
(109) Pemphigus
-
(110) Peripheral neuropathy
-
(111) Perivenous encephalomyelitis
-
(112) Pernicious anemia
-
(113) POEMS syndrome
-
(114) Polyarteritis nodosa
-
(115) Type I, II & III autoimmune polyglandular syndromes
-
(116) Polymyalgia rheumatica
-
(117) Polymyositis
-
(118) Postmyocardial infarction syndrome
-
(119) Postpericardiotomy syndrome
-
(120) Progesterone dermatitis
-
(121) Primary biliary cirrhosis
-
(122) Primary sclerosing cholangitis
-
(123) Psoriasis
-
(124) Psoriatic arthritis
-
(125) Idiopathic pulmonary fibrosis
-
(126) Pyoderma gangrenosum
-
(127) Pure red cell aplasia
-
(128) Raynauds phenomenon
-
(129) Reactive Arthritis
-
(130) Reflex sympathetic dystrophy
-
(131) Reiter’s syndrome
-
(132) Relapsing polychondritis
-
(133) Restless legs syndrome
-
(134) Retroperitoneal fibrosis
-
(135) Rheumatic fever
-
(136) Rheumatoid arthritis
-
(137) Sarcoidosis
-
(138) Schmidt syndrome
-
(139) Scleritis
-
(140) Scleroderma
-
(141) Sjogren’s syndrome
-
(142) Sperm & testicular autoimmunity
-
(143) Stiff person syndrome
-
(144) Subacute bacterial endocarditis (SBE)
-
(145) Susac’s syndrome
-
(146) Sympathetic ophthalmia
-
(147) Takayasu’s arteritis
-
(148) Temporal arteritis/Giant cell arteritis
-
(149) Thrombocytopenic purpura (TTP)
-
(150) Tolosa-Hunt syndrome
-
(151) Transverse myelitis
-
(152) Type 1 diabetes
-
(153) Ulcerative colitis
-
(154) Undifferentiated connective tissue disease (UCTD)
-
(155) Uveitis
-
(156) Vasculitis
-
(157) Vesiculobullous dermatosis
-
(158) Vitiligo; and
-
(159) Other autoimmune-relegated diseases.
-
-
(b) “Individually identifiable health information” means information that is a subset of health information, including demographic information collected from an individual, and:
-
(1) is created or received by a health care provider, health plan, employer, or health care clearinghouse; and
-
(2) relates to the past, present, or future physical or mental health or condition of an individual; the provision of health care to an individual; or the past, present or future payment for the provision of health care to an individual;
-
(3) identifies the individual:
-
(A) by such common identifiers as name, address, birth date, social security number and other common identifies, or
-
(B) with respect to which there is a reasonable basis to believe the information can be used to identify the individual.
-
-
-
